Table 3.

Number and ratio for each reason of donor exclusion during phase II to IV of the living donor evaluation protocol

Phase	Step	n	Exclusion	n	% from the step
Phase II	Liver biopsy	371	Moderate steatosis	16	4.31
			Severe steatosis	9	2.42
			Portal tract fibrosis	27	7.27
			Bilharzial granuloma	10	2.69
			Reactive hepatitis change	4	1.07
			Focal portal infiltrate	1	0.26
			Portal lymphocyte infiltrate	1	0.26
			Hemosiderosis	1	0.26
			Focal necrotic areas	1	0.26
		301	Withdrawal	38	12.62
Phase III	Volumetry and anatomical assessment	263	Portal venous variants	2	0.76
			Biliary variants	6	2.28
			hepatic venous variants	8	3.04
			hepatic venous and biliary variants	1	0.38
			hepatic and portal venous variants	3	1.14
			Small for size graft	15	5.70
			Small residual left lobe	4	1.50
		224	Withdrawal	9	4.01
Phase IV	Informed consent	215	Withdrawal	3	1.39
	Donors underwent surgery	212